Global US Healthcare Advertising Market
US Healthcare Advertising Market Analysis Report 2024-2032: Increasing Presence of Generic and Me-too Drugs, Increased Consumer Reach through Mobile Advertising, Strict Rules and Regulations by FDA
March 08, 2024 06:35 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "US Healthcare Advertising Market Report by Product Type (Pharmaceuticals (Small Molecule Drugs), Biopharmaceuticals, Vaccines, Over-The-Counter (OTC)...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
March 06, 2024 04:00 ET | Rentschler Biopharma SE
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024 17:48 ET | MacroGenics, Inc.
ROCKVILLE, MD, March 01, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Bioprocess Validation Market
Bioprocess Validation Global Strategic Business Report 2024: Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
March 01, 2024 06:48 ET | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bioprocess Validation...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024 17:45 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Global Automation in Biopharma Industry Market
Automation in Biopharma Industry Propels Market Growth with Emerging Trends - Global Forecast to 2028
February 27, 2024 09:38 ET | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
Global IL-17 Biologics Market
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
February 20, 2024 10:57 ET | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
22157.jpg
Biopharmaceuticals Exicipients Research Report 2024: Market to Reach $4 Billion by 2030 - Opportunities in the Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates Markets
February 13, 2024 10:56 ET | Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Exicipents Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Single Use Bioprocessing Market to Reach USD 139.6 Billion by 2033 from USD 27.6 Billion in 2023 | CAGR of 17.6%
February 05, 2024 05:54 ET | Market.Us
New York, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Single Use Bioprocessing Market size is projected to surpass around USD 139.6 Billion by 2033, and it is poised to reach at a...
MacroGenics-Logo-(transparent-background).png
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024 16:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...